BioMed Central Blog : DIM: hope for ovarian cancer (anti-cancer drug Diindolylmethane (DIM))

"Importantly, Kandala and Srivastava also showed that DIM enhanced the anti-cancer effects of cisplatin in both human ovarian cancer cells and in mice, where a combination of both drugs reduced tumour growth by an extra 50% compared with cisplatin alone. DIM is thus an exciting potential future therapy for ovarian cancer, which could overcome the problems with cisplatin resistance in some women."